Skip to main content
Clinical Trials/NCT01430650
NCT01430650
Completed
Phase 4

A Randomised Control Trial to Evaluate Efficacy and Safety of Two Different Protocols of Endometrial Priming for Embryo Transfer.

Parc de Salut Mar1 site in 1 country140 target enrollmentJuly 2010

Overview

Phase
Phase 4
Intervention
Oral strogen
Conditions
Sterility
Sponsor
Parc de Salut Mar
Enrollment
140
Locations
1
Primary Endpoint
Difference between day means in endometrial priming to achieve 7 mm.
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The aim of this trial is compare two different endometrial priming protocols

  • women that receive oral estrogens
  • women that receive transdermal estrogens
Registry
clinicaltrials.gov
Start Date
July 2010
End Date
July 2015
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Parc de Salut Mar
Responsible Party
Principal Investigator
Principal Investigator

Miguel Angel Checa

MD

Parc de Salut Mar

Eligibility Criteria

Inclusion Criteria

  • Women between 18-50 years old with desire of children and needs of embryo transfer.
  • Plasma prolactin less than
  • Uterine cavity that allow pregnancy, body mass index between 20-
  • And signed consent inform.

Exclusion Criteria

  • History of estrogen dependent cancer, unknown origin vaginal bleeding.
  • Ovarian cyst.
  • Contraindications to be pregnant.
  • Estrogen allergy.

Arms & Interventions

Oral strogen

Intervention: Oral strogen

Transdermal strogen

Intervention: Transdermal strogen

Outcomes

Primary Outcomes

Difference between day means in endometrial priming to achieve 7 mm.

Time Frame: 11-16 days

Secondary Outcomes

  • Biochemical Pregnancy rate(26-30 days)
  • The patient's adherence to the recommended treatment.(1-16 days)

Study Sites (1)

Loading locations...

Similar Trials